Text Size

Assessment of GRASP Medical Device to Improve Arm Coordination After Stroke

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of Nottingham
ClinicalTrials.gov Identifier:
NCT01134796
First received: May 28, 2010
Last updated: January 19, 2012
Last verified: January 2012
History of Changes
  Purpose

Assessment of a custom made grasp device in the rehabilitation of stroke victims.


Condition
Stroke

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assessment of GRASP II

Further study details as provided by University of Nottingham:

Estimated Enrollment: 75
Study Start Date: June 2010
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Stroke pateints and healthy volunteers (controls)

Criteria

Inclusion Criteria:

  1. Damage to the following areas of the brain, all of which may be involved in coordination of reach to grasp confirmed by CT scan: parietal, cerebellar, internal capsule and basal ganglia,
  2. A score of 6 or more on the arm section of the Rivermead Motor Assessment (able to reach and pick up a tennis ball and release on thigh),
  3. Time between start of hand opening and start of hand transport > 60 ms (measured with GRASP).

Exclusion Criteria:

  1. Cognitive dysfunction which prevents understanding of the task,
  2. Severe concurrent medical problems that prevent repetitive reaching (including shoulder pain),
  3. A diagnosis of Parkinson's disease, or
  4. Lack of informed consent.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: University of Nottingham
ClinicalTrials.gov Identifier: NCT01134796     History of Changes
Other Study ID Numbers: 09103
Study First Received: May 28, 2010
Last Updated: January 19, 2012
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Additional relevant MeSH terms:
Stroke
Cerebral Infarction
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on May 19, 2013